Delivery Order SPE2DB20D3303-SPE2DB26FY2K4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,891.75 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price contract is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,148.50 for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, made on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside procurement. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) with a ceiling value of $1,722.87. This firm fixed-price delivery order, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) valued at $7,179.96. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single fulfillment action under a larger contracting vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) under a firm fixed-price contract valued at $8,854.17. The order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order represents a transaction...
- The Defense Logistics Agency awarded a $29,065.41 delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on November 7, 2025, with completion due by November 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,825.23 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $3,103.31. This firm fixed-price delivery order, which is expected to be completed by November 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,982.71 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) with a ceiling value of $3,100.69. The contract was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and utilizes firm fixed pricing. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, reflecting open...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2K4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $7,349.03. The award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location, leveraging its capabilities as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The prime IDC demonstrates AmerisourceBergen's established status as a critical pharmaceutical vendor within the federal medical supply chain and its ability to fulfill diverse medication requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 11/6/25 |